Unveiling the future of oncology: Specialized teams at Florida Cancer Specialists & Research Institute target advanced cancer treatments

FCS Disease Site Committee formed

FORT MYERS, Fla., May 21, 2024 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) is proud to announce an initiative aimed at revolutionizing cancer care – the introduction of designated FCS Disease Site Teams for late-stage research and the subsequent formation of the FCS Disease Site Committee. With an unwavering commitment to excellence in cancer research and treatment, FCS sets a new standard in personalized care by engaging specialized teams to focus on specific cancer types in late-stage trials.

Led by world-renowned FCS medical oncologists and hematologists and supported by a multidisciplinary team of experts, each Disease Site team is prepared to address the unique challenges and intricacies associated with various cancer types, particularly in late-stage research. These efforts will complement the early-stage research conducted in each of FCS's Drug Development Units (DDUs) under the supervision of FCS Director of Drug Development Manish R. Patel, MD. By concentrating their expertise and resources, these site-specific teams are able to drive groundbreaking advances in the understanding, diagnosis and treatment of advanced cancer.

“We believe that by combining our collective knowledge and resources into dedicated late-stage research teams, we can accelerate progress in bringing promising therapies to patients who urgently need them,” said Dr. Lucio N. Gordan, president and chief medical officer at FCS. “The Disease Site Committee embodies our commitment to providing unparalleled care and expanding the frontiers of oncology research.”

The Disease Site Teams will focus on a range of cancers in late-stage trials, including breast cancer, gynecological cancers, gastrointestinal cancer, skin cancer and breast cancer. Each team will leverage superior technologies, work closely with FCS research partner Sarah Cannon Research Institute and participate in clinical trials to advance innovative approaches in cancer treatment for patients in advanced stages of the disease.

Members of the FCS Disease Site Committee include:


Gastrointestinal (GI) tract

Urogenital (GU)

Gynecology (GYN) and others

head and neck




“Our goal is to improve outcomes for patients with advanced cancer and contribute to the global fight against cancer in its many forms,” ​​added Bradley J. Monk, MD, Medical Director of Late-Stage Research at FCS. “With these specialized teams, we aim to gain new insights, develop novel therapies and ultimately change the landscape of oncology.”

As part of its commitment to transparency and patient-centered care, FCS will regularly communicate updates and findings from the Disease Site Committee. Through knowledge sharing and collaboration, the nationwide practice maintains its mission to provide patient-centered care and inspire hope through science and innovation.

For more information about the FCS Disease Site Committee, visit:

About Florida Cancer Specialists & Research Institute, LLC: (
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Most new cancer drugs recently approved in the United States have been studied in clinical trials with FCS participation.* In recognition of our research, FCS received the American Society of Clinical Oncology (ASCO) National Clinical Trials Participation Award. . FCS physicians, trained at prestigious medical schools and research institutes, are consistently ranked as top physicians nationwide by U.S. News & World Report.

We're celebrating his 40thTh In 2024, FCS has established a national reputation for excellence reflected in exceptional and compassionate patient care based on innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genome-based treatment and immunotherapy. Our highest values ​​are embodied by our outstanding team of highly qualified and dedicated physicians, clinicians and staff.

(PRNewsphoto/Florida Cancer Specialists & Research Institute)

Decision View original content to download multimedia:

SOURCE Florida Cancer Specialists & Research Institute

Anna Harden

Learn More →

Leave a Reply

Your email address will not be published. Required fields are marked *